Combination chemotherapy in oat cell carcinoma of the lung
- 1 September 1975
- Vol. 36 (3), 867-872
- https://doi.org/10.1002/1097-0142(197509)36:3<867::aid-cncr2820360307>3.0.co;2-1
Abstract
Twenty-eight patients with oat cell carcinoma of the lung were treated with cyclophosphamide, vincristine, procarbazine, and prednisone with and without irradiation. Median survival was significantly increased in this treatment group (10 months) as compared to a retrospective radiation alone series (5 months). Intensive chemotherapy with this four-drug regimen represents an initial step in effective management of this disorder.Keywords
This publication has 9 references indexed in Scilit:
- Combination chemotherapy and radiation therapy in small cell carcinoma of the lungCancer, 1973
- Case 28-1973New England Journal of Medicine, 1973
- Lung cancer: Clinical trial of radiotherapy alone vs. Radiotherapy plus cyclophosphamideCancer, 1972
- Intensive combined chemotherapy and radiotherapy in patients with nonresectable bronchogenic carcinomaCancer, 1972
- FIVE-YEAR FOLLOW-UP OF THE MEDICAL RESEARCH COUNCIL COMPARATIVE TRIAL OF SURGERY AND RADIOTHERAPY FOR THE PRIMARY TREATMENT OF SMALL-CELLED OR OAT-CELLED CARCINOMA OF THE BRONCHUS: A REPORT TO THE MEDICAL RESEARCH COUNCIL WORKING PARTY ON THE EVALUATION OF DIFFERENT METHODS OF THERAPY IN CARCINOMA OF THE BRONCHUSThe Lancet, 1969
- Alkylating agents in bronchogenic carcinomaAmerican Journal Of Medicine, 1969
- Controlled study of survival of patients with clinically inoperable lung cancer treated with radiation therapyAmerican Journal Of Medicine, 1966
- Cell Type and the Natural History of Lung CancerJAMA, 1965
- Meaningful clinical classification of therapeutic responses to anticancer drugsCancer Cell, 1961